Prix Sinco Pharmaceuticals Holdings Limited (06833.HK)

Sinco Pharmaceuticals Holdings Ltd. engages in the marketing, promotion, and channel management services for pharmaceutical products and medical devices. The company is headquartered in Chengdu, Sichuan and currently employs 268 full-time employees. The company went IPO on 2016-03-10. The firm mainly operates its businesses through three segments. The Sale of Imported Pharmaceutical Products segment engages in marketing, promotion and channel management activities for the sales of improved human plasma-based pharmaceuticals, antibiotics and other pharmaceuticals focused on therapeutic areas and complementary to human plasma-based products and other categories. The Research and Manufacturing of Aesthetic Medicine segment engages in the research, development and manufacture of aesthetic medicine. The Medical Beauty Services segment engages in the provision of medical beauty services. The firm mainly conducts its business in the domestic market.